Square Pharma approves 43pc dividend

Square Pharmaceuticals Ltd has approved cash dividend @ 36 per cent and stock dividend (bonus share) @ 7.0 per cent for its shareholders for the year ended on June 30, 2018.
The approval came on Thursday at the 52nd Annual General Meeting of the company held at Dhaka Club Ltd in the city, said a statement.
The AGM was presided over by the Chairman of the Company Samuel S Chowdhury.
Ratna Patra, Vice Chairman; Tapan Chowdhury, Managing Director; Nihad Kabir, Independent Director; Md. Kabir Reza, Chief Financial Officer and Khandaker Habibuzzaman, Company Secretary attended the meeting.
According to the latest annual report, the consolidated turnover, gross profit and net profit for the year ended 30 June, 2018 were Tk. 45,887 million, Tk. 19,564 million and Tk. 11,606 million respectively.
Turnover and net profit rose 8.52 per cent and 9.0 per cent respectively during the year under review.
The company contributed an amount of Tk. 7,687 million to the national exchequer.
The Board of Directors appreciates the performance of the officers, staff and workers whose untiring efforts helped to optimize the profit of the Company. The Directors expressed their gratitude and acknowledged with keen interest the co-operation and unflinching support received from various agencies including Bangladesh Securities and Exchange Commission, DSE and CSE, National Board of Revenue and other agencies of the public and private sector.
Shareholders attended the AGM and many of them took part in the discussion regarding company's performance and future expansion. At the end Mr. Samuel S Chowdhury, Chairman and Mr. Tapan Chowdhury, Managing Director expressed their deep appreciation to shareholders for their support and confidence in the company's performance.